AIRS's Quality Score rose 1 point on Mon, Nov 2, to -7.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 3.5% today, more than its doctors & clinic peers' 2.9%; no story names it yet.
Up 44% since Oct 26
Up 44% so far from Oct 26 to Nov 2.
| Since its Dec 2021 high | Down 90% |
| Latest filing | 10-Q, Aug 10 |
TodayNo story names it yet.
After its last 4 reports it closed -5.9% on average, higher 2 of 4 times.
Poorfor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
AIRS is #5 of 5 by Quality Score among Services-Offices & Clinics of Doctors of Medicine.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| 5 |
Expected to report Mon Nov 9, before the open (in 7 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
AIRS's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Adjusted EBITDA | about $12M to $14M |
Sales grew 19% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 2.8% a year over 3 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 10, 2026 | -42.8% | -45.1% | -31.5% |
| May 8, 2026 | +6.7% | +11.6% | +37.0% |
| Mar 16, 2026 | +54.9% | +51.6% | +43.2% |
Sales grew in four of the last six years, to $152M in 2025. It made a profit in two of the seven years.
Officers and directors with a Form 4 in the last 12 months.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
“While we believe we are transforming the body contouring market, our primary competition includes individual and small practice group providers of traditional liposuction, which we believe require a longer patient recovery time than AirSculpt ® and some national providers of other minimally-invasive techniques, which we believe are less effective than AirSculpt ® .”
AIRS scores -7 today, which Breakaway calls Poor. It is #5 of 5 in Services-Offices & Clinics of Doctors of Medicine by Quality Score, with 3 of 14 chart checks firing. Up 44% so far from Oct 26 to Nov 2. Shares: 18.8% more than a year ago (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
AIRS scores -7 today, which Breakaway calls Poor (below zero). That is #5 of 5 in Services-Offices & Clinics of Doctors of Medicine by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind AIRS's -7.
Expected to report Mon Nov 9, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. AIRS closed higher after 2 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.